238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-17.80%
Negative net income growth while META stands at 1.90%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
43.37%
D&A growth well above META's 12.45%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-27.66%
Negative yoy deferred tax while META stands at 112.12%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
40.98%
SBC growth well above META's 12.42%. Michael Burry would flag major dilution risk vs. competitor’s approach.
23.13%
Slight usage while META is negative at -650.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
95.01%
AR growth well above META's 2.67%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
533.33%
Some inventory rise while META is negative at -58.91%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
22.09%
A yoy AP increase while META is negative at -172.15%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-38.33%
Both reduce yoy usage, with META at -71.53%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
31.64%
Lower 'other non-cash' growth vs. META's 75.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
6.52%
Some CFO growth while META is negative at -6.94%. John Neff would note a short-term liquidity lead over the competitor.
8.65%
Some CapEx rise while META is negative at -2.77%. John Neff would see competitor possibly building capacity while we hold back expansions.
-110.31%
Both yoy lines negative, with META at -3768.42%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-45.76%
Both yoy lines negative, with META at -14.92%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-8.13%
We reduce yoy sales while META is 284.45%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-66.17%
Both yoy lines negative, with META at -5500.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-690.42%
We reduce yoy invests while META stands at 810.19%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
25.87%
Debt repayment similar to META's 25.76%. Walter Schloss sees parallel liability management or similar free cash flow availability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.